Acute migraine treatment: patterns of use and satisfaction in a clinical population.

Abstract:

BACKGROUND:The sequence and timing of taking migraine medications, whether prescription or over-the-counter, and the patient's response to their treatment, is unknown. OBJECTIVE:To describe the use of, response to, and satisfaction with acute medications for 1 migraine attack. METHODS:We performed a clinic-based survey of 127 patients at Jefferson Headache Center, Philadelphia. Adult patients who met the International Headache Society criteria for migraine with or without aura were included in the study. Patients were asked to complete a questionnaire. RESULTS:Of 109 participants who met the inclusion criteria, most waited 1 hour or more after the onset of symptoms to take medication. Triptans were most commonly used as first, second, and third medications. Triptan use was associated with higher 2-hour pain-free response rates compared with other agents, whether the triptan was used as the first, second, or third medication. Patients who were treated with medications other than triptans were more likely to have pain at 2 hours (P = .36). NSAIDs had relatively low pain-free and headache relief response rates at 2 hours. Sixty-two participants (56.9%) had to treat a second time and 31 (28.4%) had to treat a third time. Some participants (17.6%) had headache recurrence within 24 hours after becoming headache free following initial medication and some (23.5%) had recurrence after becoming headache free following their second medication. Sixty-six percent of participants reported being very satisfied/satisfied with their initial medication and 33% were somewhat dissatisfied/dissatisfied to some degree. Even though most patients were satisfied with their medication, 88% reported that they would be willing to try a new antimigraine medication. Most patients (60 [55%]) preferred a long-acting agent versus a rapid-onset, short-acting agent (which was preferred by 49 [45%] patients). CONCLUSION:Migraine patients have treatment preferences. They generally want a drug that provides complete headache relief, and they are often satisfied with the current treatment options.

journal_name

Headache

journal_title

Headache

authors

Malik SN,Hopkins M,Young WB,Silberstein SD

doi

10.1111/j.1526-4610.2006.00437.x

subject

Has Abstract

pub_date

2006-05-01 00:00:00

pages

773-80

issue

5

eissn

0017-8748

issn

1526-4610

pii

HED437

journal_volume

46

pub_type

杂志文章

相关文献

HEADACHE文献大全
  • Cervicogenic headache: responses to nitroglycerin, oxygen, ergotamine and morphine.

    abstract::The responses in cervicogenic headache to four different agents have been studied. Nitroglycerin was given sublingually to 27 patients. Eighteen patients got more than 20% increase of their headache. Of those with any headache increase at all, 12 got bilateral and 12 unilateral pain. The typical late cluster headache ...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.1993.hed3305249.x

    authors: Bovim G,Sjaastad O

    更新日期:1993-05-01 00:00:00

  • Access to Triptans for Acute Episodic Migraine: A Qualitative Study.

    abstract:OBJECTIVE:Our study aims to examine factors related to access of triptans among multiple stakeholder groups. BACKGROUND:Triptans are a cornerstone of pain management for the acute treatment of migraine, but actual utilization of triptans is lower than ideal. Initial and continued access to triptans may be an important...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/head.12593

    authors: Khan S,Mascarenhas A,Moore JE,Knowles S,Gomes T

    更新日期:2015-07-01 00:00:00

  • Cushing syndrome induced by serial occipital nerve blocks containing corticosteroids.

    abstract::A patient with chronic daily headaches developed overt signs of Cushing syndrome during treatment with serial occipital nerve block injections. Investigation demonstrated an exogenous source of corticosteroids as the cause of the Cushing syndrome in this patient, thus, implicating the corticosteroid component of the o...

    journal_title:Headache

    pub_type: 杂志文章

    doi:

    authors: Lavin PJ,Workman R

    更新日期:2001-10-01 00:00:00

  • Reduced adverse event profile of orally inhaled DHE (MAP0004) vs IV DHE: potential mechanism.

    abstract:BACKGROUND:MAP0004 is a novel orally inhaled formulation of dihydroergotamine mesylate (DHE) currently in development that has been clinically observed to provide rapid ( approximately 10 minutes) therapeutic levels of DHE but with lower rates of adverse effects (dizziness, nausea, and paresthesia) compared with intrav...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.2009.01510.x

    authors: Cook RO,Shrewsbury SB,Ramadan NM

    更新日期:2009-11-01 00:00:00

  • A practice guide for continuous opioid therapy for refractory daily headache: patient selection, physician requirements, and treatment monitoring.

    abstract:OBJECTIVES:To provide a guide to the use and limitations of continuous opioid therapy (COT, or daily scheduled opioids) for refractory daily headache, based on the best available evidence and expert clinical experience. BACKGROUND:There has been a dramatic increase in opioid administration over the past 25 years, with...

    journal_title:Headache

    pub_type: 杂志文章,实务指引,评审

    doi:10.1111/j.1526-4610.2010.01733.x

    authors: Saper JR,Lake AE 3rd,Bain PA,Stillman MJ,Rothrock JF,Mathew NT,Hamel RL,Moriarty M,Tietjen GE

    更新日期:2010-07-01 00:00:00

  • Psychophysiological response patterns of migraine patients in two habituation tests.

    abstract:OBJECTIVE:To investigate the habituation response pattern of patients with migraine to a simple standard stressor and to a more complex performance-dependent (achievement) stressor in three peripheral systems (electrodermal, vasomotor, and cardiovascular). We hypothesized that the migraine patients would show abnormal ...

    journal_title:Headache

    pub_type: 临床试验,杂志文章

    doi:10.1111/j.1526-4610.2005.00270.x

    authors: Huber D,Henrich G,Gündel H

    更新日期:2005-11-01 00:00:00

  • Longitudinal Analysis of Patient-Reported Outcomes From an Interdisciplinary Pediatric Pain Rehabilitation Program for Children With Chronic Migraine and Headache.

    abstract:BACKGROUND:Many children suffering from chronic headache and migraine present with comorbid functional disability, including physical, social, emotional, and academic activities. For children severely impaired by headache, intensive interdisciplinary pain rehabilitation treatment (IIPT) can improve functioning. However...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/head.13389

    authors: Benore E,Webster EE,Wang L,Banez G

    更新日期:2018-11-01 00:00:00

  • Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trial.

    abstract:OBJECTIVE:To evaluate the long-term tolerability of telcagepant for acute treatment of intermittent migraine attacks. Background.- Telcagepant is a calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for the acute treatment of migraine. METHODS:Migraine patients were randomized 2:1 to double-...

    journal_title:Headache

    pub_type: 杂志文章,随机对照试验

    doi:10.1111/j.1526-4610.2010.01799.x

    authors: Connor KM,Aurora SK,Loeys T,Ashina M,Jones C,Giezek H,Massaad R,Williams-Diaz A,Lines C,Ho TW

    更新日期:2011-01-01 00:00:00

  • Life event stress and headache frequency revisited.

    abstract::Life stress is found to be related to headache frequency in some studies, but not others. Research designs that find a relationship between the two tend to evaluate young subjects and employ large sample sizes. The purpose of this study was to evaluate the relationship between headache frequency and life stress, while...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1046/j.1526-4610.2000.00016.x

    authors: Reynolds DJ,Hovanitz CA

    更新日期:2000-02-01 00:00:00

  • Cutaneous atrophy and alopecia after greater occipital nerve injection using triamcinolone.

    abstract::Greater occipital nerve (GON) infiltration is widely used for the treatment of primary and secondary headache disorders mainly on the basis of open-label evidence, although recent double-blinded placebo-controlled trials have demonstrated its efficacy in cluster headache. The procedure is generally well tolerated alth...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.2012.02270.x

    authors: Lambru G,Lagrata S,Matharu MS

    更新日期:2012-11-01 00:00:00

  • Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.

    abstract:BACKGROUND:Despite the expanding therapeutic armamentarium, many people with episodic migraine (EM) have unmet acute treatment needs. OBJECTIVE:To determine the relative frequency of prespecified types of "unmet treatment needs" in persons with EM in a US population-based sample. METHODS:Eligible participants complet...

    journal_title:Headache

    pub_type: 杂志文章,随机对照试验

    doi:10.1111/head.12154

    authors: Lipton RB,Buse DC,Serrano D,Holland S,Reed ML

    更新日期:2013-09-01 00:00:00

  • Alpha-dihydroergocryptine in the prophylaxis of migraine: a multicenter double-blind study versus flunarizine.

    abstract::This multicenter, double-blind, clinical study was designed to compare the efficacy and safety of alpha-dihydroergocryptine and flunarizine in the prophylaxis of migraine without aura. One hundred thirty-five patients fulfilling the diagnostic criteria of the International Headache Society were enrolled at five neurol...

    journal_title:Headache

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1046/j.1526-4610.1999.3906426.x

    authors: Bussone G,Cerbo R,Martucci N,Micieli G,Zanferrari C,Grazzi L,Fabbrini G,Cavallini A,Granella F,Ambrosoli L,Mailland F,Poli A,Manzoni G

    更新日期:1999-06-01 00:00:00

  • Cross-Sectional Evaluation of the Psychometric Properties of the Headache-Specific Locus of Control Scale in People With Migraine.

    abstract:OBJECTIVE:This study aims to investigate the psychometric properties (component structure, reliability, and construct validity) of the Headache-Specific Locus of Control scale in several clinical migraine populations. BACKGROUND:Headache-specific locus of control beliefs may impact a person's behavioral decisions that...

    journal_title:Headache

    pub_type: 杂志文章,随机对照试验

    doi:10.1111/head.13485

    authors: Grinberg AS,Seng EK

    更新日期:2019-05-01 00:00:00

  • Chronic tension-type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserine.

    abstract::Forty out-patients affected by chronic tension-type headache were selected according to the diagnostic criteria of International Headache Society (IHS) Headache Classification Committee. In a controlled trial patients received placebo for a four-week baseline period, then they were randomized in double-blind fashion t...

    journal_title:Headache

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1526-4610.1994.hed3401044.x

    authors: Manna V,Bolino F,Di Cicco L

    更新日期:1994-01-01 00:00:00

  • Headache disorders in children and adolescents: their association with psychological, behavioral, and socio-environmental factors.

    abstract:OBJECTIVE:This cross-sectional study on a randomly drawn population sample of children and adolescents (n = 3399; aged 9 to 15) aimed at the assessment of patterns of associations between psychosocial variables and primary headache disorders like migraine (MIG) or tension-type headache. A headache-free group served as ...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.2012.02210.x

    authors: Kröner-Herwig B,Gassmann J

    更新日期:2012-10-01 00:00:00

  • Activation of pain fibers to the internal carotid artery intracranially may cause the pain and local signs of reduced sympathetic and enhanced parasympathetic activity in cluster headache.

    abstract::Several clinical and circulatory physiological observations indicate that the internal carotid artery (ICA) with proximal pial and orbital-periorbital branches, as well as external carotid vessels adjacent to the orbital region, are involved in the autonomic symptoms of an attack of cluster headache. Evidence is prese...

    journal_title:Headache

    pub_type: 杂志文章,评审

    doi:10.1111/j.1526-4610.1991.hed3105314.x

    authors: Hardebo JE

    更新日期:1991-05-01 00:00:00

  • Familial hemiplegic migraine with crossed cerebellar diaschisis and unilateral meningeal enhancement.

    abstract::A 6-year-old boy with a family history of hemiplegic migraine had a hemiplegic migraine lasting for 6 days complicated by prolonged fever, lethargy, and two brief focal seizures. An acute single photon emission computerized tomogram (SPECT) demonstrated decreased blood flow in the symptomatic cerebral hemisphere as we...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1046/j.1526-4610.1997.3709590.x

    authors: Crawford JS,Konkol RJ

    更新日期:1997-10-01 00:00:00

  • Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women.

    abstract::A retrospective study was conducted on 1300 women suffering from migraine without aura referred to the Headache Centers of Parma and Pavia from 1984 to 1990. All the data concerning their reproductive life, and the modifications induced by it on the course of headache were obtained from record-charts. Migraine frequen...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.1993.hed3307385.x

    authors: Granella F,Sances G,Zanferrari C,Costa A,Martignoni E,Manzoni GC

    更新日期:1993-07-01 00:00:00

  • Genetic biomarkers for migraine.

    abstract::Biomarkers are physical signs or laboratory measurements that occur in association with a pathological process and have putative diagnostic and/or prognostic utility. In migraine, clinical, radiological, and biochemical biomarkers might be helpful to improve diagnosis, get insight in pathophysiology, and facilitate tr...

    journal_title:Headache

    pub_type: 杂志文章,评审

    doi:10.1111/j.1526-4610.2006.00499.x

    authors: De Vries B,Haan J,Frants RR,Van den Maagdenberg AM,Ferrari MD

    更新日期:2006-07-01 00:00:00

  • Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial.

    abstract:BACKGROUND:Eletriptan is a potent 5-HT(1B/1D) agonist with proven efficacy in the acute treatment of migraine in adults. OBJECTIVE:To evaluate the efficacy and tolerability of eletriptan 40 mg versus placebo in adolescent patients (aged 12-17). METHODS:A multicenter, double-blind, parallel-group, placebo-controlled t...

    journal_title:Headache

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1111/j.1526-4610.2007.00755.x

    authors: Winner P,Linder SL,Lipton RB,Almas M,Parsons B,Pitman V

    更新日期:2007-04-01 00:00:00

  • The role of cranial computed tomography in the diagnostic work-up of headache.

    abstract::Approximately 18% of all patients referred for a cranial computed tomography complain of headache only. We reviewed 363 consecutive patients in order to assess the value of this examination in the diagnostic approach. Despite the vast number of normal examinations (88.4%), we advocate the routine use of a cranial comp...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1046/j.1526-4610.1996.3606347.x

    authors: Demaerel P,Boelaert I,Wilms G,Baert AL

    更新日期:1996-06-01 00:00:00

  • Genetics of migraine: an update.

    abstract::Observations including the long-recognized tendency of migraine to run in families, the high concordance rates for migraine in twins reared together or apart, and the association of specific mutations with a rare migraine form are consistent with a genetic contribution to the disorder. This paper summarizes major find...

    journal_title:Headache

    pub_type: 杂志文章,评审

    doi:10.1111/j.1526-4610.2006.00486.x

    authors: Gardner KL

    更新日期:2006-06-01 00:00:00

  • Low dose flunarizine in the prophylaxis of migraine.

    abstract::In a period of one year (1990) we selected 40 patients suffering from migraine. For an open randomized study there were 2 groups of patients: the first were treated with 10mg of flunarizine per day and the second with 3 mg per day. The patients were treated for 4 months consecutively. There were 11 drop outs (27.5%): ...

    journal_title:Headache

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1526-4610.1992.hed3208390.x

    authors: Bassi P,Brunati L,Rapuzzi B,Alberti E,Mangoni A

    更新日期:1992-09-01 00:00:00

  • Antihistamine responsive cluster headache in a teenaged girl.

    abstract::Episodic cluster headache is a well-recognized entity usually starting in the second decade of life. Uncommonly, the first typical symptoms may present in the first decade of life, but are rarely recognized as such during childhood. We report a 12-year-old girl who presented with a 1-year history of bouts of right-sid...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1046/j.1526-4610.1997.3705296.x

    authors: Neubauer D,Kuhar M,Ravnik IM

    更新日期:1997-05-01 00:00:00

  • Obesity and migraine: the effect of age, gender and adipose tissue distribution.

    abstract:OBJECTIVE:To evaluate the prevalence of migraine/severe headaches in those with and without general obesity and abdominal obesity (Abd-O) and the effect of gender and age on this relationship. BACKGROUND:General, or total body obesity (TBO), as estimated by body mass index, is a risk factor for migraine chronification...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.2009.01459.x

    authors: Peterlin BL,Rosso AL,Rapoport AM,Scher AI

    更新日期:2010-01-01 00:00:00

  • Migraine headaches and mood/anxiety disorders in the ELSA Brazil.

    abstract:OBJECTIVE:To describe the relationship between mood/anxiety disorders and migraine headaches emphasizing the frequency of episodes based in a cross-sectional analysis in the Brazilian Longitudinal Study of Adult Health. BACKGROUND:It has been suggested that frequency of migraine headaches can be directly associated wi...

    journal_title:Headache

    pub_type: 杂志文章,多中心研究

    doi:10.1111/head.12397

    authors: Goulart AC,Santos IS,Brunoni AR,Nunes MA,Passos VM,Griep RH,Lotufo PA,Benseñor IM

    更新日期:2014-09-01 00:00:00

  • Illness Perception and Job Satisfaction in Patients Suffering from Migraine Headaches: Trait Anxiety and Depressive Symptoms as Potential Mediators.

    abstract:BACKGROUND AND OBJECTIVES:Migraine headache is the seventh leading cause of disability worldwide causing adverse outcomes in many aspects of an individual's life. Many psychological aspects affect chronic migraine (CM): illness perception, anxiety, depressive symptoms, and job satisfaction. This observational study aim...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/head.13461

    authors: Rogante E,Sarubbi S,Lamis DA,Canzonetta V,Sparagna A,De Angelis V,Erbuto D,Martelletti P,Pompili M

    更新日期:2019-01-01 00:00:00

  • The Use and Method of Action of Intravenous Lidocaine and Its Metabolite in Headache Disorders.

    abstract:BACKGROUND:Lidocaine, an amide anesthetic, has been used in the treatment of a wide variety of pain disorders for over 75 years. In addition to pain control, lidocaine is an anti-arrhythmic agent and has anti-inflammatory properties. Lidocaine's unique properties, including nonlinear pharmacokinetics, have limited its ...

    journal_title:Headache

    pub_type: 杂志文章,评审

    doi:10.1111/head.13298

    authors: Berk T,Silberstein SD

    更新日期:2018-05-01 00:00:00

  • Persistent migraine aura: new cases, a literature review, and ideas about pathophysiology.

    abstract:BACKGROUND:Persistent migraine aura without infarction (PMA) is a rare condition that is defined as an aura that lasts longer than 1 week in absence of infarction. Two types of PMA have been distinguished, notably persistent primary visual disturbance (PPVD) and typical aura (TA). OBJECTIVES:This case-based review art...

    journal_title:Headache

    pub_type: 杂志文章,评审

    doi:10.1111/head.12392

    authors: Thissen S,Vos IG,Schreuder TH,Schreurs WM,Postma LA,Koehler PJ

    更新日期:2014-09-01 00:00:00

  • Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraine.

    abstract:BACKGROUND:Although naratriptan is not approved for prophylactic use in migraine, naratriptan has been shown to be significantly more effective than placebo for short-term prevention of menstrually related migraine (MRM). The tolerability of naratriptan administered intermittently for prophylaxis for MRM over the long ...

    journal_title:Headache

    pub_type: 临床试验,杂志文章

    doi:10.1111/j.1526-4610.2007.00809.x

    authors: Brandes JL,Smith T,Diamond M,Ames MH

    更新日期:2007-06-01 00:00:00